CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers

Preventive Medicine

Volumn 41, Issue 2, 2005, Pages 651-656

  Ohsawa, Masaki ^a   Okayama, Akira ^b   Nakamura, Motoyuki ^a   Onoda, Toshiyuki ^a   Kato, Karen ^a   Itai, Kazuyoshi ^a   Yoshida, Yuki ^a   Ogawa, Akira ^a   Kawamura, Kazuko ^c   Hiramori, Katsuhiko ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c Health Service Association   (Japan)

Author keywords

C reactive protein; Cardiovascular disease; Cross sectional study; Iwate KENCO study; Smoking cessation

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; COMPARATIVE STUDY; CORRELATION ANALYSIS; GEOMETRY; HUMAN; MALE; MULTIVARIATE ANALYSIS OF COVARIANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SMOKING CESSATION;

ADULT; AGED; ANALYSIS OF VARIANCE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; HUMANS; JAPAN; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SMOKING; SMOKING CESSATION; TIME FACTORS;

EID: 21144446440     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2005.02.002     Document Type: Article

References (25)

1. R. Ross Atherosclerosis-An inflammatory disease N. Engl. J. Med. 340 1999 115 126
2. J. Yudkin, M. Kumari, and S. Humphries Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148 2 2000 209 214
3. W. Kannel Hypertension, blood lipids, and cigarette smoking as co-risk factors for coronary heart disease Ann. N. Y. Acad. Sci. 304 1978 128 139
4. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project J. Chron. Dis.: The Pooling Project Research Group 1978 201 306
5. The Health Consequences of Smoking-Cardiovascular Disease W. A report of the surgeon general Rockville, MD: United States Department of Health and Human Services; 1983.
6. L. Kuller, R. Tracy, and J. Shaten for the MRFIT research group: relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study Am. J. Epidemiol. 144 1996 537 547
7. W. Koenig, M. Sund, and M. Frolich C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged man: results from the MONICA (MONI-toring trends and determinants in CArdiovascular disease) Ausburg Cohort Study, 1984 to 1992 Circulation 99 1999 237 242
8. M. Fröhlich, M. Sund, and H. Lowel Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Ausburg Survey 1994/95) Eur. Heart J. 24 14 2003 1365 1372
9. W. Roberts, L. Moulton, and T. Law Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications Part 2 Clin. Chem. 47 2001 418 425
10. M. Roivainen, M. Viik-Kajander, and T. Palosuo Infections, inflammation, and the risk of coronary heart disease Circulation 101 2000 252 257
11. R. Tracy, R. Lemaitre, and B. Psaty Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the cardiovascular health study and the rural health promotion project Arterioscler. Thromb. Vasc. Biol. 17 1997 1121 1127
12. M. Mandel, D. Strachen, and B. Butland C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men Eur. Heart J. 21 2002 1584 1590
13. P. Ridker, M. Cushman, and M. Stampfer Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N. Engl. J. Med. 336 1997 973 979
14. P. Ridker, C. Hennekens, and J. Buring C reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N. Engl. J. Med. 342 2000 836 843
15. N. Rost Plasma concentration of c-reactive protein and risk of ischemic stroke and transient ischemic attack. The Framingham study Stroke 32 2001 2575 2579
16. P. Ridker, M. Cushman, and M. Stampfer Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease Circulation 97 1998 425 428
17. M. Crook, D. Scott, and J. Stapleton Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation Eur. J. Clin. Invest. 30 10 2000 861 865
18. PM. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
19. A. Imhof, M. Froelich, and H. Brenner Effect of alcohol consumption on systemic markers of inflammation Lancet 357 2001 763 767
20. M. Albert, R. Glynn, and P. Ridker Alcohol consumption and plasma concentration of C-reactive protein Circulation 107 2003 443 447
21. E. Ford Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults Epidemiology 13 2002 561 568
22. J. Smith, R. Dykes, and J. Douglas Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease JAMA 281 1999 1722 1727
23. R. Tracy, B. Psaty, and E. Macy Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects Arterioscler. Thromb. Vasc. Biol. 17 1997 2167 2176
24. R. Doll, and R. Peto Mortality in relation to smoking: 20 years' observations on male British doctors Br. Med. J. 2 1976 1525 1536
25. W. Craig, G. Palomaki, and J. Haddow Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data Br. Med. J. 298 1989 784 788